Ding; Yanbing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ding; Yanbing.The latest application filed is for "analogs of celastrol".

Company Profile

2.19.27

Ding; Yanbing - Richmond CA
Ding; Yanbing - Shanghai CN
DING; Yanbing - Pudong New Area CA
Ding; Yanbing - Vancouver CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Analogs Of Celastrol App 20210061851 - Mazitschek; Ralph ; et al.	2021-03-04
Analogs of celastrol Grant 10,662,218 - Mazitschek , et al.	2020-05-26
Analogs Of Celastrol App 20180362575 - Mazitschek; Ralph ; et al.	2018-12-20
Pyrimidine Hydroxy Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20170096403 - van Duzer; John H. ; et al.	2017-04-06
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof Grant 9,409,890 - van Duzer , et al. August 9, 2	2016-08-09
N-piperidinyl Acetamide Derivatives As Calcium Channel Blockers App 20160175315 - PAJOUHESH; Hassan ; et al.	2016-06-23
N-piperidinyl acetamide derivatives as calcium channel blockers Grant 9,096,522 - Pajouhesh , et al. August 4, 2	2015-08-04
Pyrimidine Hydroxy Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20140142104 - van Duzer; John H. ; et al.	2014-05-22
Oxopiperazine derivatives for the treatment of pain and epilepsy Grant 8,629,149 - Pajouhesh , et al. January 14, 2	2014-01-14
N-piperidinyl Acetamide Derivatives As Calcium Channel Blockers App 20140011996 - Pajouhesh; Hassan ; et al.	2014-01-09
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof Grant 8,614,223 - van Duzer , et al. December 24, 2	2013-12-24
N-piperidinyl acetamide derivatives as calcium channel blockers Grant 8,569,344 - Pajouhesh , et al. October 29, 2	2013-10-29
N-piperidinyl Acetamide Derivatives As Calcium Channel Blockers App 20130065926 - PAJOUHESH; Hassan A. ; et al.	2013-03-14
N-piperidinyl acetamide derivatives as calcium channel blockers Grant 8,377,968 - Pajouhesh , et al. February 19, 2	2013-02-19
Substituted aryl sulfone derivatives as calcium channel blockers Grant 8,304,434 - Chakravarty , et al. November 6, 2	2012-11-06
Substituted Heterocyclic Derivatives For The Treatment Of Pain And Epilepsy App 20120220603 - Pajouhesh; Hassan ; et al.	2012-08-30
Oxopiperazine Derivatives For The Treatment Of Pain And Epilepsy App 20120220605 - Pajouhesh; Hassan ; et al.	2012-08-30
Pyrimidine Hydroxy Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20120121502 - van Duzer; John H. ; et al.	2012-05-17
Bicyclic pyrimidine derivatives as calcium channel blockers Grant 8,133,998 - Pajouhesh , et al. March 13, 2	2012-03-13
Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers App 20100210620 - Chakravarty; Prasun K. ; et al.	2010-08-19
Diaryl Piperidine Compounds As Calcium Channel Blockers App 20100168103 - Pajouhesh; Hassan ; et al.	2010-07-01
Urea derivatives as calcium channel blockers Grant 7,659,395 - Pajouhesh , et al. February 9, 2	2010-02-09
Heterocyclic Compounds As Calcium Channel Blockers App 20100029681 - Pajouhesh; Hassan ; et al.	2010-02-04
Urea derivatives as calcium channel blockers Grant 7,649,092 - Pajouhesh , et al. January 19, 2	2010-01-19
N-piperidinyl Acetamide Derivatives As Calcium Channel Blockers App 20090298883 - PAJOUHESH; Hassan ; et al.	2009-12-03
Heterocyclic Amide Derivatives As Calcium Channel Blockers App 20090221603 - Pajouhesh; Hassan ; et al.	2009-09-03
Diamine calcium channel blockers Grant 7,511,077 - Pajouhesh , et al. March 31, 2	2009-03-31
N-type calcium channel blockers Grant 7,507,760 - Pajouhesh , et al. March 24, 2	2009-03-24
Amino acid derivatives as calcium channel blockers App 20090012010 - Galemmo, JR.; Robert ; et al.	2009-01-08
Bicyclic Pyrimidine Derivatives As Calcium Channel Blockers App 20080280900 - PAJOUHESH; Hassan ; et al.	2008-11-13
Urea Derivatives As Calcium Channel Blockers App 20080221117 - PAJOUHESH; Hassan ; et al.	2008-09-11
Urea Derivatives As Calcium Channel Blockers App 20080207633 - Pajouhesh; Hassan ; et al.	2008-08-28
Urea derivatives as calcium channel blockers Grant 7,378,420 - Pajouhesh , et al. May 27, 2	2008-05-27
N-type calcium channel blockers Grant 7,244,758 - Pajouhesh , et al. July 17, 2	2007-07-17
Diamine calcium channel blockers App 20060235050 - Pajouhesh; Hassan ; et al.	2006-10-19
Urea derivatives as calcium channel blockers App 20060063775 - Pajouhesh; Hassan ; et al.	2006-03-23
Diarylamine derivatives as calcium channel blockers App 20050227999 - Pajouhesh, Hassan ; et al.	2005-10-13
N-type calcium channel blockers App 20050165065 - Pajouhesh, Hassan ; et al.	2005-07-28
N-type calcium channel blockers App 20050014748 - Pajouhesh, Hassan ; et al.	2005-01-20
Novel structures and compositions comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease, its underlying conditions including hyperlipidemia and other disorders having inflammation as part of their aetiology App 20040236125 - Kutney, James P. ; et al.	2004-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.